CTMX CytomX Therapeutics Inc.

11.26
+0.33  (+3%)
Previous Close 10.93
Open 10.95
Price To Book 4.16
Market Cap 510207085
Shares 45,311,464
Volume 382,755
Short Ratio
Av. Daily Volume 473,486

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 updated data at ASCO June 1, 2019.
CX-072 - PROCLAIM-CX-072
Solid tumors
Phase 1/2 preliminary data due 2019.
BMS-986249 and nivolumab
Solid Tumors or Lymphomas
Phase 1/2 updated data at AACR April 2, 2019. 7/71 partial responses.
CX-2009 - PROCLAIM
Solid tumors

Latest News

  1. CytomX Therapeutics Announces Presentations at 2019 ASCO Annual Meeting
  2. CytomX Therapeutics, Inc. (CTMX) Q1 2019 Earnings Call Transcript
  3. Edited Transcript of CTMX earnings conference call or presentation 9-May-19 9:00pm GMT
  4. Were Hedge Funds Right About Dumping CytomX Therapeutics, Inc. (CTMX)?
  5. CytomX Therapeutics (CTMX) Reports Q1 Loss, Tops Revenue Estimates
  6. CytomX Therapeutics: 1Q Earnings Snapshot
  7. CytomX Therapeutics Announces First Quarter 2019 Financial Results
  8. Edited Transcript of CTMX earnings conference call or presentation 6-Nov-18 10:00pm GMT
  9. CytomX Therapeutics to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
  10. CytomX Therapeutics to Announce First Quarter 2019 Financial Results
  11. Analysts Estimate CytomX Therapeutics (CTMX) to Report a Decline in Earnings: What to Look Out for
  12. Long-Term "GameChangers" in Biotech
  13. CytomX Therapeutics Appoints Elaine V. Jones, Ph.D., to Board of Directors
  14. What Kind Of Investor Owns Most Of CytomX Therapeutics, Inc. (NASDAQ:CTMX)?
  15. Consider These 3 Falling Knives
  16. AACR 2019 Presentations Highlight CX-2009, a First-In-Class Probody Drug Conjugate Targeting Novel Tumor Antigen, CD166
  17. The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs
  18. CytomX Therapeutics Announces Transition of Chief Financial Officer
  19. Have Insiders Been Buying CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares?
  20. CytomX to Present at Upcoming Healthcare Conferences